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Genetic Analysis of SCN5A Gene in Patients of Long QT 
Syndrome 
Uzma Zaheen1, Memona Yasmin1, Saadia Noreen1, Saqib Ali2*, Allah Rakha1 
ackground: Finding out the cause of death is the main concern in forensic casework, particularly in 
sudden unexplained death cases. Long QT syndrome is a form of life debilitating cardiac arrhythmia. 
Among LQT genes, LQT3 is suggested to be more lethal and patients are at high probability of sudden 
death as compared to LQT1 and LQT2 patient.  
Methods: Samples of long QT patients were collected and the coding regions of all exons of the SCN5A, voltage- 
gated Na+ channel gene were screened by sequencing for the potential mutations as the causative agent of long 
QT syndrome.  
Results: After data analysis, 3 genetic variations have been found, amongst them are 2 heterozygous mutations 
that were reported previously in other ethnicity G87A-A29A found in exon 2, G1673A-H558R in exon 12 and 
one novel mutation that has not been reported so far, G>A 1238-G412G resulting in a transition mutation and 
change in amino acid GGG- Glycine to GAG- glutamic acid at position 412 in exon 9. While in other exons, no 
significant mutation was found. 
Conclusion: As some of the exons showed mutation and the sample size was small, however, further functional 
analysis of the gene is needed with large number of samples for the confirmation of results. 
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Introduction  
In the developed states, sudden cardiac death (SCD) is 
the commonest cause of death, where about 70-80 % 
deaths are due to cardiac abnormalities [1]. Long QT 
syndrome is one of the main causes of SCD.  It is very 
rare with a prevalence of 1 in 10,000 to 15,000 
individuals. Pathogenic variants causing Long QT 
syndrome has been identified in 13 genes such as LQT1 
(KCNQ1), LQT2 (KCNH1), LQT3 (SCN5A), KCNE1, 
KCNJ2, KCNJ5, RYR2, SCN4B, ANK2, CACNAK, CAV3 
and KCNE2 [2]. The pathogenic mutations in LQT1, 
LQT2 & LQT3 are responsible for 80% of long QT 
syndrome [3].  
A significant number of deaths, particularly in the 
young, are due to inherited heart disorders, both for 
structural and functional heart disease [4]. In recent 
decades, a large number of developments have been 
done to understand the genetic cause of SCD [5]. It is 
important to rule out the genetic cause of sudden death 
being the reason that other family members are also in 
danger of having a fatal cardiac condition. Recent 
studies show a rate of 30–200/100,000 individuals every 
year [6], bringing about around 335,000 passing every 
year in the USA. Similarly, in Europe, the rate is 
obviously higher in Northern nations. There are many 
possible factors that could lead to the sudden cardiac 
death like hypertrophic cardiomyopathy, coronary 
artery abnormalities and long QT syndrome. Post-
mortem genetic estimation, or “molecular autopsy” is 
becoming progressively significant in the evaluation of 
sudden death cases, mainly for identification of 
pathogenic alterations in genes underlying disease [7]. 
This strategy may have an important effect on the 
screening of family members at risk, but still it is not a 
routine component of post-mortem testing [8]. 
Association of several genes with LQT is reported 
previously like LQT1 (KCNQ1), LQT2 (KCNH2), LQT3 
(SCN5A), KCNE1, KCNJ2, KCNJ5 and KCNE2.  The LQT1 
gene, also known as KCNQ1, accounts for 30-35% of all 
LQT cases. It is positioned at chromosome 11p15.5 and 
encodes voltage-gated potassium channels.  LQT2 form 
is the second common gene, situated on chromosome 7, 
accounts for 25 to 30% of all LQT cases [9]. The third 
gene responsible for the LQT syndrome is LQT3 gene, 
also known as SCN5A, accounts for 5-10% of all LQT 
cases [10]. The sodium channel gene is situated on 3rd 
chromosome p21, it consists of 28 exons. It encodes 
protein of 2,016 amino acids [11]. 
SCN5A, voltage-gated sodium channel gene. It is 
dominantly expressed in the heart [12]. The mutations 
in SCN5A slow down or inactivate the sodium channel, 
as a result delaying in depolarization. The persistent late 
Na+ current extends the plateau phase of action 
potential and causes long QT segment in ECG.  Variants 
related to SCN5A gene encodes the α-subunit of the 
cardiac sodium channel (Nav1.5), results in a range of 
disease individuals, labeled as sodium channelopathies 
[11].  
Mutations in SCN5A gene are known to cause sudden 
unexpected death syndrome, a situation frequently 
encounter in forensic science [13]. In present study, the 
mutant variant of SCN5A gene in LQT syndrome 
patients has been identified. Subsequently, this study 
could be extended to ‘molecular autopsy’ for the doctors 
to diagnose the LQT syndrome by the help of genetic 
testing in sudden death cases to resolve the query of 
unexplained and unexpected sudden deaths. 
Methods 
Sample collection 
Six samples were collected after complete evaluation of 
patients from two Hospitals of Lahore, Pakistan. The 
patients of congenital Long QT Syndrome diagnosed by 
cardiologist were ascertained from pediatric cardiology 
ward, Children Hospital Lahore, Pakistan and cardiology 
department, PIC Lahore, Pakistan. The patients of Long 
QT were selected on the basis of Schwartz’s LQTS, 
Diagnostic criteria (2006) [14]. An informed consent was 
obtained from the affected individuals in written form. 
The consent for patient below 12 year was taken from 
his/her parents. The blood samples were taken in EDTA 
containing vacutainers and stored at 4oC for further use. 
The relevant clinical data i.e. age, family history, ECG 
records and other related health information was 
recorded. The confidentiality of the data has been 
maintained in strict accordance with the protocol 
approved by ethical committee of the institute.  
Extraction and Quantification of DNA  
The Phenol Chloroform Isoamyl alcohol method was 
used for DNA extraction [15]. The quality and quantity 
of the extracted DNA was estimated by using agarose gel 
electrophoresis (0.8 %) and gel documentation system 
(Bio Red System) (Fig. SF1, SF2). 
Primer Designing 
The primers used for this work were retrieved from the 
literature as reported by Park et al., [11] (Table ST1).  
Primer optimization   
The primers for all the exons were optimized via 
gradient PCR (Figure SF3). 
DNA amplification  
The DNA regions of selected exons of SCN5A were 
amplified by using conventional PCR (Table ST2, Figure 
SF1).  
Resolution of PCR product on gel 
The size of the PCR products of all the exons were 
visually examined by resolving the amplicons on agarose 
gel (Figure SF4, SF5).
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DNA Sequencing and Analysis 
The amplified DNA was sequenced, and the data was 
analyzed by using Chromas Lite v2.01 software. The 
sequence of each exon was blast against the normal 
reference sequence of SCN5A by using BLAST (Basic 
Local Alignment Search Tool) sequence server on NCBI 
website.  
Results 
The exons of SCN5A gene were sequenced of six 
samples. After the sequence analysis, three genetic 
variations were identified, two of them are heterozygous 
type and one is missense mutation. One of the 
heterozygous mutations (G87A-A29A) was found in 
exon 2 of sample C4 (E2 C4) (Figure 1), there is 
heterozygosity of G and A at position 87 resulting GCG 
to GCA both are alanine at position 29. The other 
heterozygous mutation (G1673A-H558R) is 1673G>A in 
exon 12 of sample C3 (E12 C3) (Figure 2) resulting in a 
change of amino acid to CAC-Histidine (H) to CGC- 
Arginine(R) at position 558. The third mutation 
(missense) was identified in exon 9, where a substitution 
of G to A at 1238 position (G>A 1238-G412G) was 
detected and change in amino acid GGG- Glycine to 
GAG- glutamic acid at position 412 (Figure 3A, 3B). The 
transition mutation was found in all six samples (C1-C6) 
(Figure SF4, SF5) (Table 1). For the verification of 
mutational analysis, the sequenced data was compared 
with the Punjabi population data that is available on 
1000 Genomes. The comparative analysis showed that 
no mutation (87G>A-A29A, 1238G>A-G412G, 1673G>A-
H558R) was detected in the control data (Table 1). 
Sample 
ID  
Exon no. Nucleotide 
change 
Amino acid 
change 
Genotype 
C4 EXON 2 87G>A A29A Heterozygosity 
C1 Exon 9 1238G>A G412G Substitution 
C2 Exon 9 1238G>A G412G Substitution 
C3 Exon 9 1238G>A G412G Substitution 
C4 Exon 9 1238G>A G412G Substitution 
C5 Exon 9 1238G>A G412G Substitution 
C6 Exon 9 1238G>A G412G Substitution 
C3 Exon 12 1673G>A H558R Heterozygosity 
Table 1: Overall Spectrum of Mutations Observed in SCN5A Gene of LONG QT 
SYNDROME 
 
Figure 1: Electropherogram of mutation 87G>A (A29) in exon 2 of SCN5A compared 
with wild type sequence 
 
Figure 2:  Electropherogram of mutation 1673G>A (H558R) in exon 12 of SCN5A 
compared with wild type sequence 
 
Figure 3A: Omega software showing the mutation 1238G>A (G412G) in exon 9 of 
SCN5A. 
 
Figure 3B:  Enhanced view. The arrow shows the mutation (G>A) in all samples E9C1-
E9C6. The first row is the reference sequence, it shows G (in purple color) while rest 
of the 6 rows has A (green color) 
Discussion  
Several SCN5A variations have been reported in other 
countries. These variations are associated with different 
cardiac diseases like LQTS, Brs, AV block, conduction 
defect, AF, VF, and overlapping syndrome [16]. Few 
studies has been reported so far, to find out the genetic 
variations of SCN5A gene with reference to Long QT 
Syndrome, although previously many studies related to 
SCN5A variation associated with various cardiac disease 
like Bruganda syndrome, progressive cardiac conduction 
defect, AF, AV conduction block and overlapping 
syndrome [17]. Park et al., in 2012 worked on Korean 
population and found mutational change in exon 2, 12, 
17, 20, 28 of SCN5A gene [11].  Splawski et al., in  2000 
found that most of the mutations in SCN5A gene were 
located in exon 23 to 28 [18]. Iwasa et al., in 2000 
checked the polymorphism of LQTS genes in Japanese 
population; they reported 20 SNPS in 4 genes of LQTS 
and their allelic frequencies, 7 polymorphism detected 
in LQT1, 6 in LQT2, 5 in SCN5A and 2 in KCNEI [19]. 
They found polymorphism in SCN5A at exon 28, 12, 18, 
24, and 28. Keller et al., in 2003 found the novel 
mutation in SCN5A gene located at exon 26 [20]. Wang 
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et al., in 2005 observed that a SNP R1193Q of the SCN5A 
gene is noted in few overall communities, although its 
occurrence fluctuates in different ethnic foundation 
with frequency of 0.2% to 12%. Characterization of ECG 
findings revealed that individuals having R1193Q are at 
expanded danger of causing LQTS [21].  
According to a study conducted in Korean 
population 2012, a number of SCN5A variations were 
found in AV block patients [11]. The mutations, G87A-
A29A and IVS9-3C > A, identified through this study had 
already been reported in West literature, while T5457C- 
D1819D SNP has been reported in Asian literature [22]. 
A1673G-H558R is situated on sodium channel, and past 
studies revealed that this H558R variant can alter the 
phenotype of disease-producing SCN5A mutations. 
A1673G-H558R was notorious in 18% of USA 
population, 8% of Japanese communities. G87A-A29A a 
common SNP found in Han Chinese population [11]. 
H558R variant causes change in amino acid in 
sodium channel gene. It is a common polymorphism 
with frequency of 20–30% in Caucasian people. The 
single change in amino acid didn’t produce any 
symptoms, but it can help to produce lethal changes in 
SCN5A gene [23]. 
In 2014, Boehringer et al., conducted a study, 
according to him 4 variants (87G>A, 1673A>G, IVS16-
6C>T and 5457T>A) determined common variants of 
which only 1673A>G (His558Arg) was a missense variant 
because in which there is change in amino acid [24]. It 
was found that the two SCN5A variants G87A-A29A and 
G1673A-H558R are also present in local Pakistani 
population. Along with that a novel variant G>A 1238-
G412G was also identified. 
In conclusion, the 3 important genetic variants of 
SCN5A gene have been found. However, a functional 
analysis of the mutation is also suggested to confirm the 
pathogenicity of the disease. 
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